ArticleJTCVS techniques2026
Anatomic implantation technique for biventricular support with dual ventricular assist devices.
Article in JTCVS techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Bridge-to-heart transplantation with a single HeartMate 3 (HM3) left ventricular assist device has been a proven solution for end-stage heart failure. Some patients require durable right ventricle support for poor baseline biventricular function. We have successfully used dual HM3s in a biventricular configuration to bridge patients to transplant. Methods: This report discusses, in 8 straightforward yet detailed steps, our technique to implant 2 HM3 devices for dual-chamber support. Results: In total, 45 successful implants with this configuration of dual HM3 devices have been performed, the greatest reported volume in North America. We supported 1 patient for more than 3 years with durable dual biventricular assist devices, and he was eventually bridged to heart transplantation. More than 50% of our dual biventricular assist device cohort has subsequently received heart transplantation. Conclusions: Dual HM3 implantation is alternative form of durable biventricular support. Benefits include the length of bridge therapy, the potential for home discharge, enhanced rehabilitation capabilities, and weight loss. This single-center experience demonstrates that this technique can be used to successfully bridge a patient to heart transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.